It is worth noting that there is evidence showing that NF-κB is important in determining the balance between tumorigenicity and anti-tumor properties of macrophages (164, 165), and modulating the function of NF-κB might be promising to improve the efficiency of cancer immunotherapy. The gene discussed is NFKB1; the disease is neoplasm.